M. Luján

发表

Screening and prostate-cancer mortality in a randomized European study.

B. G. Blijenberg, T. H. van der Kwast, H. D. de Koning, 2009, The New England journal of medicine.

Prostate-cancer mortality at 11 years of follow-up.

B. G. Blijenberg, T. H. van der Kwast, H. D. de Koning, 2012, The New England journal of medicine.

Extent of prostate-specific antigen contamination in the Spanish section of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

M. Luján, A. Berenguer, Á. Páez, 2006, European urology.

[Mortality due to prostate cancer in the Spanish arm of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Results after a 15-year follow-up].

M. Luján, A. Berenguer, Á. Páez, 2012, Actas urologicas espanolas.

Mortality due to prostate cancer in the Spanish arm of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Results after a 15-year follow-up

M. Luján, A. Berenguer, Á. Páez, 2012 .

Climate and epidemiological characteristics of renal colic attendances in an urban setting in Spain

M. Luján, C. Pascual, C. Martín, 2011 .

[Climate and epidemiological characteristics of renal colic attendances in an urban setting in Spain].

M. Luján, C. Pascual, C. Martín, 2011, Actas urologicas espanolas.

Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening

T. Tammela, A. Auvinen, S. Moss, 2015, Clinical Cancer Research.

Four‐year prostate‐specific antigen progression in the non‐cancer population of the European Randomized Study of Screening for Prostate Cancer

M. Luján, A. Berenguer, Á. Páez, 2003, BJU international.

PSA-use in a Spanish industrial area.

M. Luján, A. Berenguer, M. A. de la Cal, 2002, European urology.

Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing: New Insights from the European Randomized Study of Screening for Prostate Cancer.

H. D. de Koning, T. Tammela, A. Auvinen, 2015, European urology.

Prostate cancer detection is also relevant in low prostate specific antigen ranges.

M. Luján, A. Berenguer, Á. Páez, 2004, European urology.

Baseline PSA in a Spanish male population aged 40-49 years anticipates detection of prostate cancer.

M. Luján, J. Angulo, H. Gimbernat, 2015, Actas urologicas espanolas.

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

T. Tammela, A. Villers, S. Moss, 2014, The Lancet.

The effect of study arm on prostate cancer treatment in the large screening trial ERSPC

E. Steyerberg, T. Tammela, A. Villers, 2010, International journal of cancer.

Reliability of the Routine Cytological Diagnosis in Bladder Cancer

M. Luján, A. Berenguer, M. A. de la Cal, 1999, European Urology.

Polyphenols in red wine inhibit the proliferation and induce apoptosis of LNCaP cells

A. Ferruelo, M. Luján, A. Berenguer, 2002, BJU international.

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC).

Harry J de Koning, Anssi Auvinen, Jack Cuzick, 2009, European urology.

Detecting circulating prostate cells in patients with clinically localized prostate cancer: clinical implications for molecular staging

A. Ferruelo, M. Luján, A. Berenguer, 2000, BJU international.

A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer.

T. H. van der Kwast, H. D. de Koning, T. Tammela, 2019, European urology.

Curriculum in Urology: Phimosis and Circumcision in Children

Y. Homma, U. Steiner, K. Miller, 1999, European Urology.

Prostate specific antigen density. Is there a role for this parameter when screening for prostate cancer?

M. Luján, A. Berenguer, Á. Páez, 2001, Prostate Cancer and Prostatic Diseases.

Role of autonomic innervation in rat prostatic structure maintenance: a morphometric analysis.

M. Luján, A. Berenguer, Á. Páez, 1998, The Journal of urology.

Update of the results of the Spanish branch of the European randomized study on screening for prostate cancer (ERSPC)

M. Luján, A. Berenguer, Á. Páez, 2015 .

Prostate cancer incidence and mortality in the Spanish section of the European Randomized Study of Screening For Prostate Cancer (ERSPC)

M. Luján, A. Berenguer, Á. Páez, 2014, Prostate Cancer and Prostatic Disease.

Prostate cancer detection and tumor characteristics in men with multiple biopsy sessions

M. Luján, A. Berenguer, Á. Páez, 2004, Prostate Cancer and Prostatic Diseases.

Prostate specific antigen variation in patients without clinically evident prostate cancer.

M. Luján, A. Berenguer, Á. Páez, 1999, The Journal of urology.

Final Results of a Screening Campaign for Prostate Cancer

M. Luján, A. Berenguer, Á. Páez, 1999, European Urology.

Prostate-specific antigen screening for prostate cancer in males older than 75 years

M. Luján, Á. Páez, 2019, Medicina Clínica (English Edition).

A 16-year Follow-up of the European Randomized study of Screening for Prostate Cancer

A. Auvinen, A. Villers, V. Nelen, 2019 .

The efficacy of prostate‐specific antigen screening: Impact of key components in the ERSPC and PLCO trials

E. Feuer, H. D. de Koning, Ruth Etzioni, 2018, Cancer.

T. Tammela, A. Villers, V. Nelen, 2021, European urology open science.

Quantitative real-time reverse transcription: polymerase chain reaction of prostate-specific antigen (PSA) for detection of circulating prostatic cells in patients with clinically localized prostate cancer

A. Ferruelo, M. Luján, A. Berenguer, 2005, Prostate Cancer and Prostatic Diseases.

[Clinical course of prostatic abscess treated with transperineal drainage].

M. Luján, A. Berenguer, C. Llorente, 1996, Actas Urológicas Españolas.

Screening and prostate-cancer mortality in a randomized European study.

B. G. Blijenberg, H. D. de Koning, T. Tammela, 2009, The New England journal of medicine.

Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer.

D. Nieboer, T. Tammela, A. Villers, 2023, European urology.

Prostate Cancer Metastatic Prostate Cancer Incidence and Prostate-specific Antigen Testing : New Insights from the European Randomized Study of Screening for Prostate Cancer

T. Tammela, A. Auvinen, A. Villers, 2015 .

Long-term prostate-specific antigen contamination in the Spanish arm of the European Randomized Study of Screening for Prostate Cancer (ERSPC)

M. Luján, A. Berenguer, Á. Páez, 2016 .

Long-term prostate-specific antigen contamination in the Spanish arm of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

M. Luján, A. Berenguer, Á. Páez, 2016, Actas urologicas espanolas.